Last updated on May 2020

A Study to Test the Efficacy and Safety of Inhaled TD139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Brief description of study

This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of TD139.

Detailed Study Description

This study is designed to evaluate the efficacy and safety of TD139, a galectin-3 inhibitor, administered by dry powder inhalation over 52 weeks. Subjects will continue on their existing standard of care (SoC), including pirfenidone or nintedanib. Two doses of TD139, each given once per day, will be compared to placebo. A follow up period of up to 52 weeks, where the subjects remain on their designated treatment, will provide valuable information on the longer-term safety of TD139 in IPF.

Clinical Study Identifier: NCT03832946

Find a site near you

Start Over

SEC Clinical Research

Andalusia, AL United States
  Connect »

Palmtree Clinical Research Inc

Palm Springs, CA United States
  Connect »

Paradigm Research

Redding, CA United States
  Connect »

Broward Research Center

Pembroke Pines, FL United States
  Connect »

Avanza Medical Research Center

Pensacola, FL United States
  Connect »

Coastal Pulmonary Critical Care PLC

Saint Petersburg, FL United States
  Connect »

The Emory Clinic

Atlanta, GA United States
  Connect »

DC Research Works

Marietta, GA United States
  Connect »

University of Maryland

Baltimore, MD United States
  Connect »

The Lung Research Center LLC

Chesterfield, MO United States
  Connect »

Pulmonlx LLC

Greensboro, NC United States
  Connect »

University of Cincinnati

Cincinnati, OH United States
  Connect »

Thomas Jefferson University

Philadelphia, PA United States
  Connect »

Glenfield Hospital

Leicester, United Kingdom
  Connect »

Wythenshawe Hospital

Manchester, United Kingdom
  Connect »

Newcastle Royal Victoria Infirmary

Newcastle Upon Tyne, United Kingdom
  Connect »

UZ Antwerp

Antwerp, Belgium
  Connect »

Nottingham City Hospital

Nottingham, United Kingdom
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.